Medicine Man Technologies Crescita futura
Future criteri di controllo 0/6
Medicine Man Technologies is forecast to grow revenue at 6% per annum.
Informazioni chiave
n/a
Tasso di crescita degli utili
n/a
Tasso di crescita dell'EPS
Pharmaceuticals crescita degli utili | 23.7% |
Tasso di crescita dei ricavi | 6.0% |
Rendimento futuro del capitale proprio | n/a |
Copertura analitica | Low |
Ultimo aggiornamento | 07 Oct 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
12/31/2025 | 191 | N/A | 21 | 26 | 2 |
12/31/2024 | 173 | N/A | -8 | -3 | 3 |
6/30/2024 | 175 | -68 | -1 | 7 | N/A |
3/31/2024 | 174 | -61 | 0 | 9 | N/A |
12/31/2023 | 172 | -43 | 2 | 12 | N/A |
9/30/2023 | 169 | -41 | 8 | 20 | N/A |
6/30/2023 | 166 | -39 | 11 | 23 | N/A |
3/31/2023 | 168 | 2 | -8 | 7 | N/A |
12/31/2022 | 159 | -26 | -7 | 7 | N/A |
9/30/2022 | 146 | 9 | -10 | 4 | N/A |
6/30/2022 | 134 | 10 | -14 | -3 | N/A |
3/31/2022 | 121 | -18 | 3 | 10 | N/A |
12/31/2021 | 108 | 7 | 3 | 8 | N/A |
9/30/2021 | 90 | -7 | -2 | 1 | N/A |
6/30/2021 | 65 | -11 | -6 | -4 | N/A |
3/31/2021 | 40 | -22 | -7 | -6 | N/A |
12/31/2020 | 24 | -19 | -11 | -10 | N/A |
9/30/2020 | 19 | -14 | -10 | -9 | N/A |
6/30/2020 | 15 | -13 | -12 | -11 | N/A |
3/31/2020 | 12 | -15 | -11 | -10 | N/A |
12/31/2019 | 11 | -17 | -8 | -8 | N/A |
9/30/2019 | 9 | -18 | -10 | -10 | N/A |
6/30/2019 | 9 | -11 | -1 | -1 | N/A |
3/31/2019 | 9 | -2 | -1 | 0 | N/A |
12/31/2018 | 8 | 1 | -1 | -1 | N/A |
9/30/2018 | 7 | 5 | 4 | 4 | N/A |
6/30/2018 | 5 | -1 | -1 | -1 | N/A |
3/31/2018 | 4 | -5 | N/A | -1 | N/A |
12/31/2017 | 3 | -5 | N/A | -1 | N/A |
9/30/2017 | 2 | -6 | N/A | -1 | N/A |
6/30/2017 | 2 | -6 | N/A | -1 | N/A |
3/31/2017 | 1 | -1 | N/A | -1 | N/A |
12/31/2016 | 1 | -1 | N/A | -1 | N/A |
9/30/2016 | 1 | 0 | N/A | 0 | N/A |
6/30/2016 | 1 | 0 | N/A | 0 | N/A |
3/31/2016 | 1 | 0 | N/A | 0 | N/A |
12/31/2015 | 1 | 0 | N/A | 0 | N/A |
9/30/2015 | 1 | 0 | N/A | 0 | N/A |
12/31/2014 | 0 | 0 | N/A | 0 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: Insufficient data to determine if SHWZ's forecast earnings growth is above the savings rate (2.5%).
Guadagni vs Mercato: Insufficient data to determine if SHWZ's earnings are forecast to grow faster than the US market
Guadagni ad alta crescita: Insufficient data to determine if SHWZ's earnings are expected to grow significantly over the next 3 years.
Ricavi vs Mercato: SHWZ's revenue (6% per year) is forecast to grow slower than the US market (8.9% per year).
Ricavi ad alta crescita: SHWZ's revenue (6% per year) is forecast to grow slower than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Insufficient data to determine if SHWZ's Return on Equity is forecast to be high in 3 years time